CN115486542A - Composite probiotic powder beneficial to lipid-lowering metabolism and preparation method thereof - Google Patents
Composite probiotic powder beneficial to lipid-lowering metabolism and preparation method thereof Download PDFInfo
- Publication number
- CN115486542A CN115486542A CN202211117988.0A CN202211117988A CN115486542A CN 115486542 A CN115486542 A CN 115486542A CN 202211117988 A CN202211117988 A CN 202211117988A CN 115486542 A CN115486542 A CN 115486542A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- probiotic powder
- lipid
- lowering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 131
- 239000006041 probiotic Substances 0.000 title claims abstract description 92
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 92
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 80
- 239000002131 composite material Substances 0.000 title claims abstract description 39
- 230000004060 metabolic process Effects 0.000 title claims abstract description 34
- 230000009286 beneficial effect Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 71
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 44
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 44
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 32
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 25
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 25
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 25
- 241000186012 Bifidobacterium breve Species 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 240000006499 Flammulina velutipes Species 0.000 claims abstract description 13
- 235000016640 Flammulina velutipes Nutrition 0.000 claims abstract description 13
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 13
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 13
- 229940054810 white kidney bean extract Drugs 0.000 claims abstract description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000001301 oxygen Substances 0.000 claims abstract description 8
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 8
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 3
- 238000004108 freeze drying Methods 0.000 claims description 35
- 238000004806 packaging method and process Methods 0.000 claims description 31
- 239000002245 particle Substances 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 24
- 244000116699 Lactobacillus acidophilus NCFM Species 0.000 claims description 14
- 235000009195 Lactobacillus acidophilus NCFM Nutrition 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 12
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 12
- 238000000227 grinding Methods 0.000 claims description 12
- 238000012216 screening Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 8
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 239000004698 Polyethylene Substances 0.000 claims description 7
- -1 polyethylene Polymers 0.000 claims description 7
- 229920000573 polyethylene Polymers 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 239000004386 Erythritol Substances 0.000 claims description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 6
- 241000191998 Pediococcus acidilactici Species 0.000 claims description 6
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 6
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 6
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 6
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 6
- 235000004634 cranberry Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 6
- 229940009714 erythritol Drugs 0.000 claims description 6
- 235000019414 erythritol Nutrition 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 4
- 230000008014 freezing Effects 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 30
- 230000000638 stimulation Effects 0.000 abstract description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 208000008589 Obesity Diseases 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 210000000941 bile Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 230000004580 weight loss Effects 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 208000015001 muscle soreness Diseases 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PZOHPVWRSNXCRP-QRCCJXOFSA-N GPL-1 Chemical compound C([C@@H](NC(=O)CC(O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCC)C(=O)N[C@H]([C@@H](C)OC1[C@@H]([C@H](O)[C@H](O)[C@H](C)O1)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)C(=O)N[C@H](C)C(=O)N[C@@H](C)COC1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)O)C1=CC=CC=C1 PZOHPVWRSNXCRP-QRCCJXOFSA-N 0.000 description 1
- 101800001586 Ghrelin Proteins 0.000 description 1
- 102000012004 Ghrelin Human genes 0.000 description 1
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3409—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor
- A23L3/3418—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor in a controlled atmosphere, e.g. partial vacuum, comprising only CO2, N2, O2 or H2O
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/44—Freeze-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses composite probiotic powder beneficial to lipid-lowering metabolism and a preparation method thereof, wherein the composite probiotic powder beneficial to lipid-lowering metabolism comprises the following raw materials in parts by weight: 190-98 parts of probiotic powder, 21-5 parts of probiotic powder, 0.01-2 parts of bifidobacterium lactis B420, 0.01-2 parts of bifidobacterium lactis HN0190.01-2 parts of bifidobacterium breve B-30.01-2 parts of lactobacillus acidophilus NCFM0.01-2 parts of lactobacillus rhamnosus 65940.01-2 parts, 299v0.01-2 parts of lactobacillus plantarum, 0.01-2 parts of potato extract, 0.01-2 parts of flammulina velutipes powder and 0.01-2 parts of white kidney bean extract. The invention has reasonable design, has good lipid-lowering and metabolism-improving effects by the cooperation of a plurality of probiotics, has obvious weight-losing effect, is suitable for wide crowds, can control oxygen and water indexes in the product, and effectively prevents external stimulation such as light, heat and the like, thereby better preserving the activity of the probiotics and ensuring the quality of the product in the shelf life.
Description
Technical Field
The invention relates to the technical field of probiotic preparations, in particular to composite probiotic powder beneficial to lipid-lowering metabolism and a preparation method thereof.
Background
For the intervention and treatment of obesity, the current lifestyle intervention combining the exercise therapy and the diet therapy is more effective and most advocated, but the efficiency is low, the period is long, and the patient is difficult to persist. Surgical intervention is also one of the effective weight loss methods, but is often high in risk and expensive, and is difficult for patients to bear; in addition, the medicine has high treatment efficiency, good effect, low risk and easy acceptance by patients, but part of the medicines can cause serious adverse reactions to the patients. Therefore, development of new natural ingredients for body fat reduction is urgently required.
At present, a large number of researches show that obesity is closely related to intestinal flora, and probiotics can reduce the serum total cholesterol and triglyceride levels of obesity model mice induced by high-fat diet, improve lipid metabolism, reduce fat accumulation in vivo and reduce body weight, thereby reducing the risk of obesity-related diseases. Some probiotic products mainly aiming at slimming are available in the market, but the disadvantages of low bacterial activity, mixed components and the like generally exist, and the quality of the products in the shelf life cannot be guaranteed, so that the composite probiotic powder which is helpful for reducing blood fat metabolism and the preparation method thereof are provided.
Disclosure of Invention
The invention aims to solve the problems in the prior art, and provides the composite probiotic powder beneficial to lipid-lowering metabolism and the preparation method thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
the composite probiotic powder helpful for lipid-lowering metabolism comprises the following raw materials in parts by weight: 190-98 parts of probiotic powder, 21-5 parts of probiotic powder, 0.01-2 parts of bifidobacterium lactis B420, 0.01-2 parts of bifidobacterium lactis HN0190.01-2 parts of bifidobacterium breve B-30.01-2 parts of lactobacillus acidophilus NCFM0.01-2 parts of lactobacillus rhamnosus 65940.01-2 parts, 0.01-2 parts of lactobacillus plantarum 299v, 0.01-2 parts of potato extract, 0.01-2 parts of flammulina velutipes powder and 0.01-2 parts of white kidney bean extract.
Preferably, the probiotic powder 1 comprises the following raw materials in parts by weight: 40-44 parts of resistant dextrin, 4-8 parts of xylo-oligosaccharide, 2-6 parts of erythritol, 34-38 parts of cranberry fruit powder, 130.3-0.7 part of lactobacillus plantarum N, 0.01-0.05 part of lactobacillus rhamnosus LRa050, 0.2-0.6 part of pediococcus acidilactici CCFM79020, 0.04-0.08 part of bifidobacterium lactis Bla, 26-30 parts of fructo-oligosaccharide and 20-24 parts of stachyose.
Preferably, the probiotic powder 2 comprises the following raw materials in parts by weight: bifidobacterium animalis CP-90.01-0.05 parts, fructo-oligosaccharide 12-16 parts, and Lactobacillus rhamnosus bv-77.04-0.08 parts.
Preferably, the number of the viable bacteria of each strain is 2-6 multiplied by 10 10 CFU/g。
A method for preparing a composite probiotic powder for aiding lipid-lowering metabolism, the method comprising the steps of:
s1, adding distilled water into a stirring kettle, adding probiotic powder 1, probiotic powder 2, bifidobacterium lactis B420, bifidobacterium lactis HN019, bifidobacterium breve B-3, lactobacillus acidophilus NCFM, lactobacillus rhamnosus 6594, lactobacillus plantarum 299v, a potato extract, flammulina velutipes powder and a white kidney bean extract into the stirring kettle one by one, stirring clockwise in the adding process at the rotation speed of 100-120r/min, continuing stirring for 26-30min after the adding is finished at the rotation speed of 160-180r/min to obtain a first mixed raw material;
s2, adjusting the temperature of a freeze drying oven to 0-4 ℃, adding the first mixed raw material into the drying oven for freeze drying, wherein the freeze drying temperature is-40 ℃ to-36 ℃, the pressure of the freeze drying oven is 1-9Pa, and the freeze drying time is 18-22h;
s3, putting the freeze-dried mixed raw material I into a granulator, and extruding and granulating the mixed raw material I until the particle size is 20-40 meshes to obtain a powder raw material I;
s4, grinding the powder raw material I for 2-4h by using a ball mill, and screening by using a vibration screening machine after grinding is finished to obtain a powder raw material II with the particle size of 160-200 meshes;
s5, treating the powder raw material II through a triple embedding technology to obtain powder particles;
s6, packaging the powder particles into a packaging shell through a packaging machine, vacuumizing and filling nitrogen into the packaging shell, and controlling the water content of the product to be 3% -7% and the oxygen content to be 1% -1.8% to obtain the composite probiotic powder beneficial to lipid-lowering metabolism.
Preferably, before step S1, bifidobacterium lactis B420, bifidobacterium lactis HN019, bifidobacterium breve B-3, lactobacillus acidophilus NCFM, lactobacillus rhamnosus 6594 and lactobacillus plantarum 299v are subjected to fermentation, freezing and drying treatment.
Preferably, in S6, the packaging shell is made of food-grade polyethylene material.
Compared with the prior art, the invention has the following beneficial effects:
1. in the application, by source adjustment, bifidobacterium lactis B420 and bifidobacterium lactis HN019 are used, the secretion of GPL-1 (glucagon-like peptide) of a human body is increased, ghrelin is reduced, and the appetite of consumers is further reduced; bifidobacterium animalis CP-9 and Lactobacillus rhamnosus bv-77 consume bile and bile acid in the digestive tract, reduce the decomposition of the bile and bile acid on fat, further reduce the absorption of the decomposed micromolecular fat by a human body, and further reduce the accumulation of the fat; bifidobacterium breve B-3 and Bifidobacterium animalis CP-9, and has effects of promoting lipodieresis in liver, reducing visceral fat, and inhibiting weight gain.
2. In the application, through the use of the multiple probiotics in a matched manner, and the composite probiotic powder and the plant active ingredients are scientifically and reasonably used in a matched manner, the generation of fat in the body can be effectively reduced, the types and the quantity of probiotics can be increased, and the growth of harmful bacteria can be inhibited, so that the selective regulation effect on the intestinal flora is achieved, the stability and the weight-losing effect of the probiotic composition are improved, and the weight-losing effect is remarkable and is suitable for wide crowds.
3. In this application, freeze-drying, triple embedding and evacuation nitrogenize technique have been used, make the bacterial can not take place the degeneration or lose life vigor, oxygen and moisture index in the help control product inner packing, simultaneously, adopted food level polyethylene packaging shell, effectively blocked external stimulus such as light, heat to preserve the probiotic activity better, guarantee the quality of product in the shelf life.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments.
Example 1
The embodiment provides composite probiotic powder beneficial to lipid-lowering metabolism, which comprises the following raw materials in parts by weight: 1 part of probiotic powder, 2 parts of probiotic powder, 0.01 part of bifidobacterium lactis B420, 0.01 part of bifidobacterium lactis HN019, 0.01 part of bifidobacterium breve B-3.01 part, 0.01 part of lactobacillus acidophilus NCFM, 0.01 part of lactobacillus rhamnosus 6594, 0.01 part of lactobacillus plantarum 299v, 0.01 part of potato extract, 0.01 part of flammulina velutipes powder and 0.01 part of white kidney bean extract, wherein the number of viable bacteria of each strain is 2 multiplied by 10 10 CFU/g, various probiotics are used in a matching way, so that the lipid-lowering health-care tea has good lipid-lowering and metabolism-improving effects, is remarkable in weight-losing effect and is suitable for wide crowds;
the probiotic powder 1 comprises the following raw materials in parts by weight: 40 parts of resistant dextrin, 4 parts of xylo-oligosaccharide, 2 parts of erythritol, 34 parts of cranberry fruit powder, 13.3 parts of lactobacillus plantarum N, 0.01 part of lactobacillus rhamnosus LRa05, 0.2 part of pediococcus acidilactici CCFM7902, 80.04 parts of bifidobacterium lactis Bla, 26 parts of fructo-oligosaccharide and 20 parts of stachyose;
wherein the probiotic powder 2 comprises the following raw materials in parts by weight: bifidobacterium animalis CP-9.01 parts, fructo-oligosaccharide 12 parts, lactobacillus rhamnosus bv-77.04 parts;
the embodiment also provides a preparation method of the composite probiotic powder for helping lipid-lowering metabolism, which comprises the following steps:
s1, adding distilled water into a stirring kettle, adding probiotic powder 1, probiotic powder 2, bifidobacterium lactis B420, bifidobacterium lactis HN019, bifidobacterium breve B-3, lactobacillus acidophilus NCFM, lactobacillus rhamnosus 6594, lactobacillus plantarum 299v, a potato extract, flammulina velutipes powder and a white kidney bean extract into the stirring kettle one by one, stirring clockwise in the adding process at the rotation speed of 100r/min, continuously stirring for 26min after the adding is finished at the rotation speed of 160r/min to obtain a first mixed raw material, and fully mixing various raw materials to uniformly distribute various strains, wherein before the step S1, fermenting, freezing and drying bifidobacterium lactis B420, lactobacillus lactis HN019, bifidobacterium breve B-3, bifidobacterium acidophilus NCFM, lactobacillus rhamnosus 6594 and lactobacillus plantarum 299 v;
s2, adjusting the temperature of a freeze drying oven to 0 ℃, adding the mixed raw material I into the drying oven for freeze drying, wherein the freeze drying temperature is-40 ℃, the pressure of the freeze drying oven is 1Pa, and the freeze drying time is 18h, and the freeze drying is carried out to ensure that the dried material can keep the original chemical composition and physical properties;
s3, putting the freeze-dried mixed raw material I into a granulator, and extruding and granulating the mixed raw material I until the particle size is 20 meshes to obtain a powder raw material I;
s4, grinding the powder raw material I for 2 hours by using a ball mill, and after grinding is finished, screening by using a vibration screening machine to obtain a powder raw material II with the particle size of 160 meshes;
s5, processing the powder raw material II through a triple embedding technology to obtain powder particles, wherein the triple embedding technology enables the composite probiotic powder to have a directional slow-release controlled-release effect, so that the composite probiotic powder is not damaged by gastric acid and bile before reaching an intestinal tract and can be absorbed by the intestinal tract, and the effect of contributing to lipid-lowering metabolism is further realized;
s6, packaging the powder particles into a packaging shell through a packaging machine, and vacuumizing and filling nitrogen into the packaging shell, wherein in S6, the packaging shell is made of food-grade polyethylene materials, external stimulation such as light, heat and the like is effectively blocked, so that the activity of probiotics is better preserved, the quality of products in a shelf life is guaranteed, the water content of the products is controlled to be 3%, and the oxygen content is controlled to be 1%, so that the composite probiotic powder beneficial to lipid-lowering metabolism is obtained.
Example 2
The embodiment provides composite probiotic powder beneficial to lipid-lowering metabolism, which comprises the following raw materials in parts by weight: 1 92 parts of probiotic powder, 2 parts of probiotic powder, 0.5 part of bifidobacterium lactis B420, 0.5 part of bifidobacterium lactis HN019, 0.5 part of bifidobacterium breve B-3.5 parts, 0.5 part of lactobacillus acidophilus NCFM, 0.5 part of lactobacillus rhamnosus 6594, 0.5 part of lactobacillus plantarum 299v, 0.5 part of potato extract, 0.5 part of flammulina velutipes powder and 0.5 part of white kidney bean extract, wherein the number of viable bacteria of each strain is 3 multiplied by 10 10 CFU/g, various probiotics are used in a matched mode, the lipid-lowering and metabolism-improving effects are good, the weight-losing effect is obvious, and the weight-losing tea is suitable for wide crowds;
wherein the probiotic powder 1 comprises the following raw materials in parts by weight: 41 parts of resistant dextrin, 5 parts of xylo-oligosaccharide, 3 parts of erythritol, 35 parts of cranberry fruit powder, 13.4 parts of lactobacillus plantarum N, 0.02 part of lactobacillus rhamnosus LRa05, 0.3 part of pediococcus acidilactici CCFM7902, 80.05 parts of bifidobacterium lactis Bla, 27 parts of fructo-oligosaccharide and 21 parts of stachyose;
wherein the probiotic powder 2 comprises the following raw materials in parts by weight: bifidobacterium animalis CP-9.02 parts, fructo-oligosaccharide 13 parts, and Lactobacillus rhamnosus bv-77.05 parts;
the embodiment also provides a preparation method of the composite probiotic powder for helping lipid-lowering metabolism, which comprises the following steps:
s1, adding distilled water into a stirring kettle, adding probiotic powder 1, probiotic powder 2, bifidobacterium lactis B420, bifidobacterium lactis HN019, bifidobacterium breve B-3, lactobacillus acidophilus NCFM, lactobacillus rhamnosus 6594, lactobacillus plantarum 299v, a potato extract, flammulina velutipes powder and a white kidney bean extract into the stirring kettle one by one, stirring clockwise in the adding process at a rotation speed of 105r/min, continuously stirring for 27min after the adding is finished, and at a rotation speed of 165r/min to obtain a mixed raw material I, and fully mixing various raw materials to uniformly distribute various strains, wherein before the step S1, the bifidobacterium lactis B420, the bifidobacterium lactis HN019, the bifidobacterium breve B-3, the lactobacillus acidophilus NCFM, the lactobacillus rhamnosus 6594 and the lactobacillus plantarum 299v are fermented, frozen and dried;
s2, adjusting the temperature of a freeze drying oven to 1 ℃, adding the mixed raw material I into the drying oven for freeze drying, wherein the freeze drying temperature is-39 ℃, the pressure of the freeze drying oven is 4Pa, and the freeze drying time is 19h, and the freeze drying is carried out to ensure that the dried material can keep the original chemical composition and physical properties;
s3, putting the freeze-dried mixed raw material I into a granulator, and extruding and granulating the mixed raw material I until the particle size is 25 meshes to obtain a powder raw material I;
s4, grinding the powder raw material I through a ball mill for 2.5 hours, and after grinding is finished, screening through a vibration screening machine to obtain a powder raw material II with the particle size of 170 meshes;
s5, treating the powder raw material II through a triple embedding technology to obtain powder particles, wherein the triple embedding technology enables the composite probiotic powder to have a directional slow-release controlled-release effect, so that the composite probiotic powder is not damaged by gastric acid and bile before reaching the intestinal tract and can be absorbed by the intestinal tract, and the effect of contributing to lipid reduction and metabolism is further achieved;
s6, packaging the powder particles into a packaging shell through a packaging machine, and vacuumizing and filling nitrogen into the packaging shell, wherein in S6, the packaging shell is made of food-grade polyethylene materials and effectively prevents external stimulation such as light, heat and the like, so that the activity of probiotics is better preserved, the quality of products in shelf life is guaranteed, the water content of the products is controlled to be 4%, and the oxygen content is controlled to be 1.2%, and the composite probiotic powder beneficial to lipid-lowering metabolism is obtained.
Example 3
The embodiment provides composite probiotic powder beneficial to lipid-lowering metabolism, which comprises the following raw materials in parts by weight: 1 part of probiotic powder, 2 parts of bifidobacterium lactis B420, 1 part of bifidobacterium lactis HN019, and 1 part of brevibacterium1 part of bifidobacterium B-3, 1 part of lactobacillus acidophilus NCFM, 6594 parts of lactobacillus rhamnosus, 299v 1 part of lactobacillus plantarum, 1 part of potato extract, 1 part of flammulina velutipes powder and 1 part of white kidney bean extract, wherein the number of viable bacteria of each strain is 4 multiplied by 10 10 CFU/g, various probiotics are used in a matching way, so that the lipid-lowering health-care tea has good lipid-lowering and metabolism-improving effects, is remarkable in weight-losing effect and is suitable for wide crowds;
wherein the probiotic powder 1 comprises the following raw materials in parts by weight: 42 parts of resistant dextrin, 6 parts of xylo-oligosaccharide, 4 parts of erythritol, 36 parts of cranberry fruit powder, 0.5 part of lactobacillus plantarum N, 0.03 part of lactobacillus rhamnosus LRa05, 0.4 part of pediococcus acidilactici CCFM7902, 0.6 part of bifidobacterium lactis Bla, 28 parts of fructo-oligosaccharide and 22 parts of stachyose;
wherein the probiotic powder 2 comprises the following raw materials in parts by weight: bifidobacterium animalis CP-9.3 parts, fructo-oligosaccharide 14 parts, and Lactobacillus rhamnosus bv-77.06 parts;
the embodiment also provides a preparation method of the composite probiotic powder for helping lipid-lowering metabolism, which comprises the following steps:
s1, adding distilled water into a stirring kettle, adding probiotic powder 1, probiotic powder 2, bifidobacterium lactis B420, bifidobacterium lactis HN019, bifidobacterium breve B-3, lactobacillus acidophilus NCFM, lactobacillus rhamnosus 6594, lactobacillus plantarum 299v, a potato extract, flammulina velutipes powder and a white kidney bean extract into the stirring kettle one by one, stirring clockwise in the adding process at the rotation speed of 110r/min, continuously stirring for 28min after the adding is finished at the rotation speed of 170r/min to obtain a mixed raw material I, and fully mixing various raw materials to uniformly distribute various strains, wherein before the step S1, the bifidobacterium lactis B420, the bifidobacterium lactis HN019, the bifidobacterium breve B-3, the lactobacillus acidophilus NCFM, the lactobacillus rhamnosus 6594 and the lactobacillus plantarum 299v are fermented, frozen and dried;
s2, adjusting the temperature of a freeze drying oven to 2 ℃, adding the mixed raw material I into the drying oven for freeze drying, wherein the freeze drying temperature is-38 ℃, the pressure of the freeze drying oven is 5Pa, and the freeze drying time is 20 hours, and the freeze drying enables the dried material to keep the original chemical composition and physical properties;
s3, putting the freeze-dried mixed raw material I into a granulator, and extruding and granulating the mixed raw material I until the particle size is 30 meshes to obtain a powder raw material I;
s4, grinding the powder raw material I for 3 hours by using a ball mill, and after grinding is finished, screening by using a vibration screening machine to obtain a powder raw material II with the particle size of 180 meshes;
s5, processing the powder raw material II through a triple embedding technology to obtain powder particles, wherein the triple embedding technology enables the composite probiotic powder to have a directional slow-release controlled-release effect, so that the composite probiotic powder is not damaged by gastric acid and bile before reaching an intestinal tract and can be absorbed by the intestinal tract, and the effect of contributing to lipid-lowering metabolism is further realized;
s6, packaging the powder particles into a packaging shell through a packaging machine, and vacuumizing and filling nitrogen into the packaging shell, wherein in S6, the packaging shell is made of food-grade polyethylene materials and effectively prevents external stimulation such as light, heat and the like, so that the activity of probiotics is better preserved, the quality of products in shelf life is guaranteed, the water content of the products is controlled to be 5%, and the oxygen content is controlled to be 1.4%, and the composite probiotic powder beneficial to lipid-lowering metabolism is obtained.
Example 4
The embodiment provides composite probiotic powder beneficial to lipid-lowering metabolism, which comprises the following raw materials in parts by weight: 1 part of probiotic powder, 2 parts of probiotic powder, 420 parts of bifidobacterium lactis, 2 parts of bifidobacterium lactis HN019, 2 parts of bifidobacterium breve B-3 parts, 2 parts of lactobacillus acidophilus NCFM, 6594 parts of lactobacillus rhamnosus, 299v 2 parts of lactobacillus plantarum, 2 parts of potato extract, 2 parts of flammulina velutipes powder and 2 parts of white kidney bean extract, wherein the number of live bacteria of each strain is 6 multiplied by 10 10 CFU/g, various probiotics are used in a matching way, so that the lipid-lowering health-care tea has good lipid-lowering and metabolism-improving effects, is remarkable in weight-losing effect and is suitable for wide crowds;
the probiotic powder 1 comprises the following raw materials in parts by weight: 44 parts of resistant dextrin, 8 parts of xylo-oligosaccharide, 6 parts of erythritol, 38 parts of cranberry fruit powder, 0.7 part of lactobacillus plantarum N, 0.05 part of lactobacillus rhamnosus LRa, 0.6 part of pediococcus acidilactici CCFM7902, 80.08 parts of bifidobacterium lactis Bla, 30 parts of fructo-oligosaccharide and 24 parts of stachyose;
the probiotic powder 2 comprises the following raw materials in parts by weight: bifidobacterium animalis CP-9.05 parts, fructo-oligosaccharide 16 parts, and Lactobacillus rhamnosus bv-77.08 parts;
the embodiment also provides a preparation method of the composite probiotic powder for helping lipid-lowering metabolism, which comprises the following steps:
s1, adding distilled water into a stirring kettle, adding probiotic powder 1, probiotic powder 2, bifidobacterium lactis B420, bifidobacterium lactis HN019, bifidobacterium breve B-3, lactobacillus acidophilus NCFM, lactobacillus rhamnosus 6594, lactobacillus plantarum 299v, a potato extract, flammulina velutipes powder and a white kidney bean extract into the stirring kettle one by one, stirring clockwise in the adding process at the rotation speed of 120r/min, continuously stirring for 30min after the adding is finished at the rotation speed of 180r/min to obtain a first mixed raw material, and fully mixing various raw materials to uniformly distribute various strains, wherein before the step S1, fermenting, freezing and drying bifidobacterium lactis B420, lactobacillus lactis HN019, bifidobacterium breve B-3, bifidobacterium acidophilus NCFM, lactobacillus rhamnosus 6594 and lactobacillus plantarum 299 v;
s2, adjusting the temperature of a freeze drying oven to 4 ℃, adding the mixed raw material I into the drying oven for freeze drying, wherein the freeze drying temperature is-36 ℃, the pressure of the freeze drying oven is 9Pa, and the freeze drying time is 22h, and the freeze drying enables the dried material to keep the original chemical composition and physical properties;
s3, putting the freeze-dried mixed raw material I into a granulator, and extruding and granulating the mixed raw material I until the particle size is 40 meshes to obtain a powder raw material I;
s4, grinding the powder raw material I for 4 hours by using a ball mill, and after grinding is finished, screening by using a vibration screening machine to obtain a powder raw material II with the particle size of 200 meshes;
s5, processing the powder raw material II through a triple embedding technology to obtain powder particles, wherein the triple embedding technology enables the composite probiotic powder to have a directional slow-release controlled-release effect, so that the composite probiotic powder is not damaged by gastric acid and bile before reaching an intestinal tract and can be absorbed by the intestinal tract, and the effect of contributing to lipid-lowering metabolism is further realized;
s6, packaging the powder particles into a packaging shell through a packaging machine, and vacuumizing and filling nitrogen into the packaging shell, wherein in S6, the packaging shell is made of food-grade polyethylene materials, external stimulation such as light, heat and the like is effectively blocked, so that the activity of probiotics is better preserved, the quality of products in a shelf life is guaranteed, the water content of the products is controlled to be 7%, and the oxygen content is controlled to be 1.8%, so that the composite probiotic powder beneficial to lipid-lowering metabolism is obtained.
The beneficial effects of the drug of the present invention are further illustrated by the following test examples.
General data:
100 obese adult patients are selected, each patient takes the product twice a day with 2g of warm boiled water below 40 ℃ after meals for 28 days continuously.
Diagnostic criteria:
obese patients had weight loss.
3. The treatment effect is as follows: (see the following Table)
Item | Effective/human | Invalid/human | Effective rate/% |
Obesity | 98 | 2 | 98 |
As can be seen from the data in the table above, after the obesity patient takes the product, the effective rate of the product for the obesity patient is 98%, and the effect is very good.
The following are individual examples of the administration of the products of the invention:
1. wholy, 28 years old, female, pre-dose symptoms: no obvious symptoms, and only overweight. After taking the product: weight loss.
2. Payment, 32 years old, female, pre-administration symptoms: overweight is associated with symptoms of shortness of breath, joint pain, muscle soreness, reduced physical activity, and anxiety. After taking the product: weight loss, body fat loss, relief of symptoms of gas urgency, joint pain, muscle soreness, increased physical activity and reduced symptoms of anxiety.
3. Some of matacia, 34 years old, male, with symptoms before administration: overweight, accompanied by dyslipidemia and hypertension. After taking the product: weight loss, dyslipidemia and relief of symptoms of hypertension.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (7)
1. The composite probiotic powder for assisting in lipid-lowering metabolism is characterized by comprising the following raw materials in parts by weight: 190-98 parts of probiotic powder, 21-5 parts of probiotic powder, 0.01-2 parts of bifidobacterium lactis B420, 0.01-2 parts of bifidobacterium lactis HN0190.01-2 parts of bifidobacterium breve B-30.01-2 parts of lactobacillus acidophilus NCFM0.01-2 parts of lactobacillus rhamnosus 65940.01-2 parts, 0.01-2 parts of lactobacillus plantarum 299v, 0.01-2 parts of potato extract, 0.01-2 parts of flammulina velutipes powder and 0.01-2 parts of white kidney bean extract.
2. The composite probiotic powder for assisting lipid-lowering metabolism according to claim 1, wherein the probiotic powder 1 comprises the following raw materials in parts by weight: 40-44 parts of resistant dextrin, 4-8 parts of xylo-oligosaccharide, 2-6 parts of erythritol, 34-38 parts of cranberry fruit powder, 130.3-0.7 part of lactobacillus plantarum N, 0.01-0.05 part of lactobacillus rhamnosus LRa050, 0.2-0.6 part of pediococcus acidilactici CCFM79020, 0.04-0.08 part of bifidobacterium lactis Bla, 26-30 parts of fructo-oligosaccharide and 20-24 parts of stachyose.
3. The composite probiotic powder for assisting lipid-lowering metabolism according to claim 2, wherein the probiotic powder 2 comprises the following raw materials in parts by weight: bifidobacterium animalis CP-90.01-0.05 parts, lactobacillus rhamnosus bv-770.04-0.08 parts and fructo-oligosaccharide 12-16 parts.
4. The composite probiotic powder for assisting lipid-lowering metabolism according to claim 3, wherein the number of viable bacteria of each strain is 2-6 x 10 10 CFU/g。
5. The method for preparing a composite probiotic powder for assisting the metabolism of lipid lowering according to any of claims 1 to 4, characterized in that it comprises the following steps:
s1, adding distilled water into a stirring kettle, adding probiotic powder 1, probiotic powder 2, bifidobacterium lactis B420, bifidobacterium lactis HN019, bifidobacterium breve B-3, lactobacillus acidophilus NCFM, lactobacillus rhamnosus 6594, lactobacillus plantarum 299v, a potato extract, flammulina velutipes powder and a white kidney bean extract into the stirring kettle one by one, stirring clockwise in the adding process at the rotating speed of 100-120r/min, continuing stirring for 26-30min after the adding is finished, and at the rotating speed of 160-180r/min to obtain a first mixed raw material;
s2, adjusting the temperature of a freeze drying oven to 0-4 ℃, adding the first mixed raw material into the drying oven for freeze drying, wherein the freeze drying temperature is-40 ℃ to-36 ℃, the pressure of the freeze drying oven is 1-9Pa, and the freeze drying time is 18-22h;
s3, putting the freeze-dried mixed raw material I into a granulator, and extruding and granulating the mixed raw material I until the particle size is 20-40 meshes to obtain a powder raw material I;
s4, grinding the powder raw material I for 2-4h by using a ball mill, and screening by using a vibration screening machine after grinding is finished to obtain a powder raw material II with the particle size of 160-200 meshes;
s5, treating the powder raw material II through a triple embedding technology to obtain powder particles;
s6, packaging the powder particles into a packaging shell through a packaging machine, vacuumizing and filling nitrogen into the packaging shell, and controlling the water content of the product to be 3% -7% and the oxygen content to be 1% -1.8% to obtain the composite probiotic powder beneficial to lipid-lowering metabolism.
6. The method for preparing composite probiotic powder for assisting lipid-lowering metabolism according to claim 5, wherein, prior to step S1, fermentation, freezing and drying treatment are performed on Bifidobacterium lactis B420, bifidobacterium lactis HN019, bifidobacterium breve B-3, lactobacillus acidophilus NCFM, lactobacillus rhamnosus 6594 and Lactobacillus plantarum 299 v.
7. The method for preparing composite probiotic powder for assisting lipid-lowering metabolism according to claim 5, wherein in S6, food-grade polyethylene material is adopted as a packaging shell.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211117988.0A CN115486542A (en) | 2022-09-14 | 2022-09-14 | Composite probiotic powder beneficial to lipid-lowering metabolism and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211117988.0A CN115486542A (en) | 2022-09-14 | 2022-09-14 | Composite probiotic powder beneficial to lipid-lowering metabolism and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115486542A true CN115486542A (en) | 2022-12-20 |
Family
ID=84468425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211117988.0A Pending CN115486542A (en) | 2022-09-14 | 2022-09-14 | Composite probiotic powder beneficial to lipid-lowering metabolism and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115486542A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117547570A (en) * | 2024-01-10 | 2024-02-13 | 广东正当年生物科技股份有限公司 | Composition containing probiotics and application of composition in preparation of weight-losing products |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111134331A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotic microcapsule and preparation method thereof |
CN111134333A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Food or health product containing probiotic microcapsules and preparation method thereof |
CN111374256A (en) * | 2018-12-29 | 2020-07-07 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotic composition, use thereof, food and medicament |
CN111374308A (en) * | 2020-04-10 | 2020-07-07 | 天津国民健康技术有限公司 | Composition for controlling sugar, reducing fat and losing weight and preparation method thereof |
US20210128649A1 (en) * | 2019-10-31 | 2021-05-06 | Ruijin Hospital, Shanghai Jiao Tong University School Of Medicine | Composition for promoting glucolipid metabolism, and preparation and application thereof |
CN113230280A (en) * | 2021-04-30 | 2021-08-10 | 华南理工大学 | Colon-targeted probiotic multilayer embedded microcapsule and preparation method and application thereof |
CN114376235A (en) * | 2022-01-26 | 2022-04-22 | 广州美春堂医药科技有限公司 | Weight-reducing probiotics and prebiotics composition beneficial to controlling in vivo fat and preparation method thereof |
CN115011513A (en) * | 2022-06-08 | 2022-09-06 | 曾俊源 | Lactic acid bacteria powder for enhancing immunity, regulating intestines and stomach to control fat, losing weight and expelling toxin |
-
2022
- 2022-09-14 CN CN202211117988.0A patent/CN115486542A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111134331A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotic microcapsule and preparation method thereof |
CN111134333A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Food or health product containing probiotic microcapsules and preparation method thereof |
CN111374256A (en) * | 2018-12-29 | 2020-07-07 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotic composition, use thereof, food and medicament |
US20210128649A1 (en) * | 2019-10-31 | 2021-05-06 | Ruijin Hospital, Shanghai Jiao Tong University School Of Medicine | Composition for promoting glucolipid metabolism, and preparation and application thereof |
CN111374308A (en) * | 2020-04-10 | 2020-07-07 | 天津国民健康技术有限公司 | Composition for controlling sugar, reducing fat and losing weight and preparation method thereof |
CN113230280A (en) * | 2021-04-30 | 2021-08-10 | 华南理工大学 | Colon-targeted probiotic multilayer embedded microcapsule and preparation method and application thereof |
CN114376235A (en) * | 2022-01-26 | 2022-04-22 | 广州美春堂医药科技有限公司 | Weight-reducing probiotics and prebiotics composition beneficial to controlling in vivo fat and preparation method thereof |
CN115011513A (en) * | 2022-06-08 | 2022-09-06 | 曾俊源 | Lactic acid bacteria powder for enhancing immunity, regulating intestines and stomach to control fat, losing weight and expelling toxin |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117547570A (en) * | 2024-01-10 | 2024-02-13 | 广东正当年生物科技股份有限公司 | Composition containing probiotics and application of composition in preparation of weight-losing products |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101616680B (en) | Agent for reducing visceral fat | |
CN107874251A (en) | A kind of eight delicacies probiotic composition with strengthening the spleen and stomach benefit function of intestinal canal | |
US20160037811A1 (en) | Fruit and vegetable product for curing oral ulcer, and preparation method therefor | |
CN110338402A (en) | A kind of compound probiotic powder and preparation method thereof | |
CN104187611A (en) | Total nutrient formula food for gastrointestinal malabsorption | |
CN115074298A (en) | Probiotic composition with effects of resisting claustrophobia, protecting stomach and promoting digestion and eliminating stagnation and application thereof | |
CN111671079A (en) | Composite probiotic powder composition and preparation method thereof | |
CN108968037A (en) | Senile dementia full nutrition formula food | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
CN115336699A (en) | Composite probiotic powder beneficial to liver health and preparation method thereof | |
CN115486542A (en) | Composite probiotic powder beneficial to lipid-lowering metabolism and preparation method thereof | |
CN102742653B (en) | Brain-strengthening and nerve soothing probiotic goat milk tablet and preparation method of brain-strengthening and nerve soothing probiotic goat milk tablet | |
CN104161263A (en) | Total nutrient formula food for children | |
KR20100119875A (en) | Agents for promoting secretion and/or suppressing decrease of adiponectin | |
CN106954673A (en) | A kind of dairy products comprising probiotics and preparation method thereof | |
KR101945207B1 (en) | Method for manufacturing a composition for enhancing intestinal environment and composition manufactured by the method | |
CN104161266A (en) | Total nutrient formula food for patients with deficiency cold of spleen and stomach | |
CN108523123A (en) | A kind of full nutritional support food of diabetes | |
CN115517370A (en) | Composite polypeptide nutrition powder for preventing cardiovascular and cerebrovascular chronic diseases and preparation method thereof | |
CN114009508A (en) | Nutritional combined milk powder for coordinating gastrointestinal health and improving obesity and preparation method thereof | |
CN115487220A (en) | Compound probiotic powder for reducing helicobacter pylori and preparation method thereof | |
CN104146266A (en) | Fully nutrient formula food for recuperating chloasma | |
CN113229365A (en) | Yoghourt helpful for improving intestinal flora and helping sleep and preparation method thereof | |
CN111990648A (en) | Probiotics powder for protecting and nourishing stomach and preparation method thereof | |
CN104187647A (en) | Full-nutritional formula food for removing acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221220 |